The following statement was issued today by Peter L. Saltonstall, President and CEO of NORD, on the confirmation by the U.S. Senate of Robert Califf, M.D., as Commissioner of the Food and Drug Administration:
“On behalf of the rare disease community, I want to congratulate Dr. Califf on being confirmed as Commissioner of the FDA. Dr. Califf has spoken to NORD in the past and is familiar with the special issues facing our community. We look forward to working with him closely in the future.”